Adherencia al tratamiento de los pacientes con diagnóstico de Artritis Idiopática Juvenil atendidos en la consulta externa de reumatología del Hospital Roberto Gilbert Elizalde en los meses de agosto del 2021 a agosto del 2022.

Abstract

Introduction: JIA is a disabling disease, which can have an impact on the quality of life of patients. To achieve the remission of the disease requires the use of some drugs, this fact can lead to a rejection by the medication and consequently poor therapeutic adherence. Methods: an observational, prospective cross-sectional descriptive study of cross-association, which included patients under 18 years of age who met certain inclusion and exclusion criteria, with a diagnosis of juvenile idiopathic arthritis attended in the Rheumatology Outpatient Clinic of the Roberto Gilbert Elizalde Hospital August 2021 to August 2022. To identify therapeutic adherence, the Morinsky-Green-Levine Test was used. Results: 51 patients met all the criteria, according to the Morinsky Green-Levine test, 52.9% were non-adherent and of the latter 31,3% were due to adverse effects and 23,5% due to forgetfulness of administration, the female sex was the least adherent with 70,4%, aged between 11 and 17 years 55,6%. Of the non-adherent cases, the highest percentage, 37%; corresponds to the polyarticular JIA Rheumatoid Factor Negative, while the metrotexate and oral corticosteroids were the drugs with which a higher percentage of non-adherence was found, 70.3 % and 59.2%. Conclusions: In this study, a higher percentage of patients non-adherent to treatment was identified, with side effects and forgetfulness in medication administration being the most frequent causes of nonadherence.